Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques

References

• Sardesai NY, Weiner DB. Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 2011; 23:421-9; PMID:21530212; http://dx.doi.org/10.1016/j.coi.2011.03.008
   PubMed Web of Science ®Google Scholar
• Flingai S, Czerwonko M, Goodman J, Kudchodkar SB, Muthumani K, Weiner DB. Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants. Front Immunol 2013; 4:354; PMID:24204366; http://dx.doi.org/10.3389/fimmu.2013.00354
   PubMed Web of Science ®Google Scholar
• Felber BK, Valentin A, Rosati M, Bergamaschi C, Pavlakis GN. HIV DNA vaccine: stepwise improvements make a difference. Vaccines 2014; 2:354-79; http://dx.doi.org/10.3390/vaccines2020354
   Google Scholar
• Hirao LA, Wu L, Khan AS, Hokey DA, Yan J, Dai A, Betts MR, Draghia-Akli R, Weiner DB. Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques. Vaccine 2008; 26:3112-20; PMID:18430495; http://dx.doi.org/10.1016/j.vaccine.2008.02.036
   PubMed Web of Science ®Google Scholar
• Winstone N, Wilson AJ, Morrow G, Boggiano C, Chiuchiolo MJ, Lopez M, Kemelman M, Ginsberg AA, Mullen K, Coleman JW, et al. Enhanced control of pathogenic SIVmac239 replication in macaques immunized with a plasmid IL12 and a DNA prime, viral vector boost vaccine regimen. J Virol 2011; 85:9578-87; PMID:21734035; http://dx.doi.org/10.1128/JVI.05060-11
   PubMed Web of Science ®Google Scholar
• Jalah R, Patel V, Kulkarni V, Rosati M, Alicea C, Ganneru B, von Gegerfelt A, Huang W, Guan Y, Broderick KE, et al. IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques. Hum Vaccin Immunother 2012; 8:1620-9; PMID:22894956; http://dx.doi.org/10.4161/hv.21407
   PubMed Web of Science ®Google Scholar
• Boyer JD, Robinson TM, Kutzler MA, Parkinson R, Calarota SA, Sidhu MK, Muthumani K, Lewis M, Pavlakis G, Felber B, et al. SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques. J Med Primatol 2005; 34:262-70; PMID:16128921; http://dx.doi.org/10.1111/j.1600-0684.2005.00124.x
   PubMed Web of Science ®Google Scholar
• Chattergoon MA, Saulino V, Shames JP, Stein J, Montaner LJ, Weiner DB. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. Vaccine 2004; 22:1744-50; PMID:15068858; http://dx.doi.org/10.1016/j.vaccine.2004.01.036
   PubMed Web of Science ®Google Scholar
• Chong SY, Egan MA, Kutzler MA, Megati S, Masood A, Roopchard V, Garcia-Hand D, Montefiori DC, Quiroz J, Rosati M, et al. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. Vaccine 2007; 25:4967-82; PMID:17335943; http://dx.doi.org/10.1016/j.vaccine.2006.11.070
   PubMed Web of Science ®Google Scholar
• Egan MA, Chong SY, Megati S, Montefiori DC, Rose NF, Boyer JD, Sidhu MK, Quiroz J, Rosati M, Schadeck EB, et al. Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus. AIDS Res Hum Retroviruses 2005; 21:629-43; PMID:16060834; http://dx.doi.org/10.1089/aid.2005.21.629
   PubMed Web of Science ®Google Scholar
• Kalams SA, Parker S, Jin X, Elizaga M, Metch B, Wang M, Hural J, Lubeck M, Eldridge J, Cardinali M, et al. Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults. PLoS One 2012; 7:e29231; PMID:22242162
   PubMed Web of Science ®Google Scholar
• Kalams SA, Parker SD, Elizaga M, Metch B, Edupuganti S, Hural J, De Rosa S, Carter DK, Rybczyk K, Frank I, et al. Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. J Infect Dis 2013; 208:818-29; PMID:23840043; http://dx.doi.org/10.1093/infdis/jit236
   PubMed Web of Science ®Google Scholar
• Robinson TM, Sidhu MK, Pavlakis GN, Felber BK, Silvera P, Lewis MG, Eldridge J, Weiner DB, Boyer JD. Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses. J Med Primatol 2007; 36:276-84; PMID:17669216; http://dx.doi.org/10.1111/j.1600-0684.2007.00245.x
   PubMed Web of Science ®Google Scholar
• Schadeck EB, Sidhu M, Egan MA, Chong SY, Piacente P, Masood A, Garcia-Hand D, Cappello S, Roopchand V, Megati S, et al. A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques. Vaccine 2006; 24:4677-87; PMID:16288822; http://dx.doi.org/10.1016/j.vaccine.2005.10.035
   PubMed Web of Science ®Google Scholar
• Hutnick NA, Myles DJ, Bian CB, Muthumani K, Weiner DB. Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo. Curr Opin Virol 2012; 1:233-40; PMID:22440782; http://dx.doi.org/10.1016/j.coviro.2011.08.003
   PubMed Web of Science ®Google Scholar
• Bodles-Brakhop AM, Heller R, Draghia-Akli R. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. Mol Ther 2009; 17:585-92; PMID:19223870; http://dx.doi.org/10.1038/mt.2009.5
   PubMed Web of Science ®Google Scholar
• Jalah R, Kulkarni V, Patel V, Rosati M, Alicea C, Bear J, Yu L, Guan Y, Shen X, Tomaras GD, et al. DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in rhesus macaques. PLoS One 2014; 9:e91550; PMID:24626482; http://dx.doi.org/10.1371/journal.pone.0091550
   PubMed Web of Science ®Google Scholar
• Li J, Valentin A, Kulkarni V, Rosati M, Beach RK, Alicea C, Hannaman D, Reed SG, Felber BK, Pavlakis GN. HIV/SIV DNA vaccine combined with protein in a Co-immunization protocol elicits highest humoral responses to envelope in mice and macaques. Vaccine 2013; 31:3747-55 ; PMID:23624057; http://dx.doi.org/10.1016/j.vaccine.2013.04.037
   PubMed Web of Science ®Google Scholar
• Patel V, Jalah R, Kulkarni V, Valentin A, Rosati M, Alicea C, von Gegerfelt A, Huang W, Guan Y, Keele BF, et al. DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous SIV challenge. Proc Natl Acad Sci U S A 2013; 110:2975-80; PMID:23359688; http://dx.doi.org/10.1073/pnas.1215393110
   PubMed Web of Science ®Google Scholar
• De Rosa SC, Thomas EP, Bui J, Huang Y, deCamp A, Morgan C, Kalams SA, Tomaras GD, Akondy R, Ahmed R, et al. HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable. J Immunol 2011; 187:3391-401; PMID:21844392; http://dx.doi.org/10.4049/jimmunol.1101421
   PubMed Web of Science ®Google Scholar
• Koup RA, Roederer M, Lamoreaux L, Fischer J, Novik L, Nason MC, Larkin BD, Enama ME, Ledgerwood JE, Bailer RT, Mascola JR, et al. Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses. PloS One 2010; 5; e9015; PMID:20126394; http://dx.doi.org/10.1371/journal.pone.0009015
   PubMed Web of Science ®Google Scholar
• Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, Koblin BA, Buchbinder SP, Keefer MC, Tomaras GD, et al. Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine. N Engl J Med 2013; 369:2083-92; PMID:24099601; http://dx.doi.org/10.1056/NEJMoa1310566
   PubMed Web of Science ®Google Scholar
• Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, Reddy S, de Pierres C, Mncube Z, Mkhwanazi N, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13:46-53; PMID:17173051; http://dx.doi.org/10.1038/nm1520
   PubMed Web of Science ®Google Scholar
• Masemola A, Mashishi T, Khoury G, Mohube P, Mokgotho P, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, et al. Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol 2004; 78:3233-43; PMID:15016844; http://dx.doi.org/10.1128/JVI.78.7.3233-3243.2004
   PubMed Web of Science ®Google Scholar
• Mothe B, Ibarrondo J, Llano A, Brander C. Virological, immune and host genetics markers in the control of HIV infection. Dis Markers 2009; 27:105-20; PMID:19893207; http://dx.doi.org/10.1155/2009/360362
   PubMed Web of Science ®Google Scholar
• Zuniga R, Lucchetti A, Galvan P, Sanchez S, Sanchez C, Hernandez A, Sanchez H, Frahm N, Linde CH, Hewitt HS, et al. Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol 2006; 80:3122-5; PMID:16501126; http://dx.doi.org/10.1128/JVI.80.6.3122-3125.2006
   PubMed Web of Science ®Google Scholar
• Rolland M, Heckerman D, Deng W, Rousseau CM, Coovadia H, Bishop K, Goulder PJ, Walker BD, Brander C, Mullins JI. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One 2008; 3:e1424; PMID:18183304; http://dx.doi.org/10.1371/journal.pone.0001424
   PubMed Web of Science ®Google Scholar
• Mothe B, Llano A, Ibarrondo J, Daniels M, Miranda C, Zamarreno J, Bach V, Zuniga R, Pérez-Álvarez S, Berger CT, et al. Definition of the viral targets of protective HIV-1-specific T cell responses. J Transl Med 2011; 9:208; PMID:22152067; http://dx.doi.org/10.1186/1479-5876-9-208
   PubMed Web of Science ®Google Scholar
• Mothe B, Llano A, Ibarrondo J, Zamarreno J, Schiaulini M, Miranda C, Ruiz-Riol M, Berger CT, Herrero MJ, Palou E, et al. CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control. PLoS One 2012; 7:e29717; PMID:22238642; http://dx.doi.org/10.1371/journal.pone.0029717
   PubMed Web of Science ®Google Scholar
• Schneidewind A, Brumme ZL, Brumme CJ, Power KA, Reyor LL, O'Sullivan K, Gladden A, Hempel U, Kuntzen T, Wang YE, et al. Transmission and long-term stability of compensated CD8 escape mutations. J Virol 2009; 83:3993-7; PMID:19091871; http://dx.doi.org/10.1128/JVI.01108-08
   PubMed Web of Science ®Google Scholar
• Honeyborne I, Prendergast A, Pereyra F, Leslie A, Crawford H, Payne R, Reddy S, Bishop K, Moodley E, Nair K, et al. Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes. J Virol 2007; 81:3667-72; PMID:17251285; http://dx.doi.org/10.1128/JVI.02689-06
   PubMed Web of Science ®Google Scholar
• Toapanta FR, Craigo JK, Montelaro RC, Ross TM. Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope. Curr HIV Res 2007; 5:199-209; PMID:17346134; http://dx.doi.org/10.2174/157016207780077057
   PubMed Web of Science ®Google Scholar
• Bockl K, Wild J, Bredl S, Kindsmuller K, Kostler J, Wagner R. Altering an artificial gagpolnef polyprotein and mode of ENV Co-administration affects the immunogenicity of a clade C HIV DNA vaccine. PLoS One 2012; 7:e34723; PMID:22509350; http://dx.doi.org/10.1371/journal.pone.0034723
   PubMedGoogle Scholar
• Kulkarni V, Rosati M, Valentin A, Ganneru B, Singh AK, Yan J, Rolland M, Alicea C, Beach RK, Zhang GM, et al. HIV-1 p24gag derived conserved element DNA vaccine increases the breadth of immune response in mice. PLos One 2013; 8:e60245; PMID:23555935; http://dx.doi.org/10.1371/journal.pone.0060245
   PubMed Web of Science ®Google Scholar
• Kulkarni V, Valentin A, Rosati M, Alicea C, Singh AK, Jalah R, Broderick KE, Sardesai NY, Le Gall S, Mothe B, et al. Altered immunodominance hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques. PLoS One 2014; 9:e86254; PMID:24465991; http://dx.doi.org/10.1371/journal.pone.0086254
   PubMed Web of Science ®Google Scholar
• Kulkarni V, Valentin A, Rosati M, Rolland M, Mullins JI, Pavlakis GN, Felber BK. HIV-1 conserved elements p24CE DNA vaccine induces humoral immune responses with broad epitope recognition in macaques. PLoS One 2014; 9:e111085; PMID:25338098; http://dx.doi.org/10.1371/journal.pone.0111085
   PubMed Web of Science ®Google Scholar
• Nabi G, Genannt Bonsmann MS, Tenbusch M, Gardt O, Barouch DH, Temchura V, Uberla K. GagPol-specific CD4(+) T-cells increase the antibody response to Env by intrastructural help. Retrovirology 2013; 10:117; PMID:24156704; http://dx.doi.org/10.1186/1742-4690-10-117
   PubMed Web of Science ®Google Scholar
• Vargas-Inchaustegui DA, Tuero I, Mohanram V, Musich T, Pegu P, Valentin A, Sui Y, Rosati M, Bear J, Venzon DJ, et al. Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggest novel combinatorial approaches for enhancing responses. Clin Immunol 2014; 153:308-22; PMID:24907411; http://dx.doi.org/10.1016/j.clim.2014.05.008
   PubMed Web of Science ®Google Scholar
• Valentin A, McKinnon K, Li J, Rosati M, Kulkarni V, Pilkington GR, Bear J, Alicea C, Vargas-Inchaustegui DA, Jean Patterson L, et al. Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques. Clin Immunol 2014; 55:91-107; PMID:25229164; http://dx.doi.org/10.1016/j.clim.2014.09.005
   PubMed Web of Science ®Google Scholar
• Rosati M, von Gegerfelt A, Roth P, Alicea C, Valentin A, Robert-Guroff M, Venzon D, Montefiori DC, Markham P, Felber BK, et al. DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J Virol 2005; 79:8480-92; PMID:15956591; http://dx.doi.org/10.1128/JVI.79.13.8480-8492.2005
   PubMed Web of Science ®Google Scholar
• Rosati M, Bergamaschi C, Valentin A, Kulkarni V, Jalah R, Patel V, von Gegerfelt AS, Montefiori DC, Venzon DJ, Khan AS, et al. DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc Natl Acad Sci U S A 2009; 06:15831-6; PMID:19717425; http://dx.doi.org/10.1073/pnas.0902628106
   PubMed Web of Science ®Google Scholar
• Kulkarni V, Rosati M, Bear J, Pilkington GR, Jalah R, Bergamaschi C, Singh AK, Alicea C, Chowdhury B, Zhang GM, et al. Comparison of intradermal and intramuscular delivery of SIV Env DNA by in vivo electroporation in macaques. Hum Vaccin Immunother 2013; 9:2081-94; PMID:23811579; http://dx.doi.org/10.4161/hv.25473
   PubMed Web of Science ®Google Scholar
• Rosati M, Valentin A, Jalah R, Patel V, von Gegerfelt A, Bergamaschi C, Alicea C, Weiss D, Treece J, Pal R, et al. Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation. Vaccine 2008; 26:5223-9; PMID:18468743; http://dx.doi.org/10.1016/j.vaccine.2008.03.090
   PubMed Web of Science ®Google Scholar